February 7, 2020: The Week in Cancer News
A roundup of the week in cancer research news from the staff of Cancer Today magazine.
Progress Against Cancer
A roundup of the week in cancer research news from the staff of Cancer Today magazine.
The number of cancer patients and survivors visiting emergency departments for opioid overdoses more than doubled between 2006 and 2015, but overdoses are still uncommon in this group.
Thanks to a wave of newly approved therapies in the past two decades, survival rates for multiple myeloma have increased dramatically. Still, the cancer research community is concerned about disparities in patient care. African Americans are disproportionately affected by multiple myeloma, having a two- to three-fold higher incidence of multiple myeloma compared with whites and representing 20 percent of the multiple myeloma patients in the U.S. Despite this difference in incidence, African Americans have historically been underrepresented in clinical trials for multiple myeloma therapies.
A study shows that some cancer patients wish they had known more about possible adverse effects of treatment.
The most impactful and informative cancer reporting and essays of 2019 selected by the editors of Cancer Today magazine.
Urologist Ardeshir Rastinehad, DO, is developing an alternative to standard laser therapy to help prostate cancer patients avoid side effects like urinary incontinence and erectile dysfunction.
New law mandates that cancer drugs get tested in kids in clinical trials.
Researchers are studying how best to support cancer caregivers.
Research indicates that only a small percentage of high-risk individuals eligible for lung cancer screening actually undergo a scan.
A new study explores the impact of lowering a patient's dose due to side effects.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More